Masterclass: Transforming Obesity Management: Digital Solutions vs. GLP-1 Blockbusters

The transformation of obesity management is at an interesting crossroads, with both the utilisation of digital solutions and GLP-1 blockbusters taking off rapidly. On one hand, digital solutions offer non-pharmacotherapeutic alternatives and scalable, personalised interventions, but challenges exist in data accuracy, user engagement and adherence to the interventions.

On the other hand, GLP-1 blockbusters offer a more targeted and pharmacological approach to obesity management. However, they come with several challenges including high costs, potential side effects, and the need for healthcare professional involvement in administration. 

A future role could involve a combination of these approaches, leveraging digital tools for tracking lifestyle factors and GLP-1 blockbusters for targeted interventions. Collaboration between healthcare providers, health tech companies, and regulatory bodies is crucial to ensure safety, efficacy, and affordability. 

If you’re interested in learning innovative solutions for obesity management and get insights on advancements, benefits, and how to integrate them into your strategies, this session is for you! 

Join this meeting …

• Considering the current landscape, which approach holds more promise in obesity management : digital solutions or GLP-1 blockbusters? Is it possible to combine the benefits of both to create a comprehensive and personalised approach? 

• In exploring the future role of obesity management, what collaboration is required between healthcare providers, technology companies, and regulatory bodies? How can these stakeholders work together to ensure the safety, efficacy, and affordability of obesity management interventions?  

• Ultimately, how can we empower individuals to take control of their health and provide them with the tools and support they need to succeed in their weight management journey?